BusinessPraxis Bioresearch Announces Peer-Reviewed Publication of Positive Data for Novel Prodrug Stimulant with Abuse-Deterrent PropertiesBy Nasdaq OMXMar 28, 2018, 12:05 PM UTC
BusinessVitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100By Nasdaq OMXJan 17, 2018, 1:01 PM UTC
BusinessVitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THCBy Nasdaq OMXJan 3, 2018, 1:31 PM UTC
BusinessPraxis Bioresearch Presents Positive Preclinical Data for Novel Prodrug Stimulant with Abuse-Deterrent Properties at ACNP Annual MeetingBy Nasdaq OMXDec 7, 2017, 12:35 PM UTC
